21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
32.99.Z - Production of other products not classified elsewhere
47.19.Z - Retail trade
47.73.Z - Retail sale of pharmaceutical products
63.12.Z - Services related to computing infrastructure, data processing, website management (hosting), and other information services
63.99.Z - Services related to computing infrastructure, data processing, website management (hosting), and other information services
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
72.11.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 25,5 | 54,3 | 140,5 | 158,9 |
EBITDA | 25,5 | 30,7 | 190,9 | 522,5 |
Income tax | ||||
Equity capital | 21,3 | -92,8 | 102,5 | 210,5 |
Operating profit (EBIT) | 25,5 | 30,7 | 140,5 | 358,4 |
Assets | 55 | 29,2 | 329,9 | 1030,2 |
Net profit (loss) | 25,5 | 54,3 | 110,4 | 103,4 |
Net income from sale | 197,6 | 203,6 | 820,4 | 302,9 |
Liabilities and provisions for liabilities | 33,7 | 122 | 227,4 | 86,4 |
Working assets | 55 | 29,2 | 329,9 | 1030,2 |
Depreciation | 0 | 0 | 50,3 | -∞ |
Basic operational activity income | ||||
% | % | % | p.p. | |
Profitability of capital | ||||
Equity capital to total assets | 38,7 | -318 | 31,1 | 349,1 |
Gross profit margin | 12,9 | 26,7 | 17,1 | -9,6 |
EBITDA Margin | 12,9 | 15,1 | 23,3 | 8,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane